| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd1692d65e3cdfb4bf587d4e6aa9ba06 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2019-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_707ef43232f120e6dfca0742510bb9c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42297014f7333c68f6ec3a057901c555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a210628296b0981f180ee281b127749 |
| publicationDate |
2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112569359-A |
| titleOfInvention |
Application of peginterferon and proto-oncogene product targeted inhibitor in synergistic treatment of renal cancer |
| abstract |
The invention discloses the application of peginterferon and a proto-oncogene product targeting inhibitor in the synergistic treatment of renal cancer. Specifically, the present invention provides the use of a combination of active components, the combination of active components comprising a pegylated (PEG) interferon and a proto-oncogene product targeting inhibitor, and the combination is used to prepare a drug for synergistic treatment of renal cancer combination. The active ingredient combination of the present invention can effectively and synergistically inhibit renal cancer, and can significantly reduce the toxic and side effects, so it can be widely used in targeted therapy of tumors. |
| priorityDate |
2019-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |